Pacific Biosciences of California (PACB) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Pacific Biosciences of California Revenue Highlights


Latest Revenue (Y)

$154.01M

Latest Revenue (Q)

$37.15M

Main Segment (Y)

Product

Main Geography (Y)

Americas

Pacific Biosciences of California Revenue by Period


Pacific Biosciences of California Revenue by Year

DateRevenueChange
2024-12-31$154.01M-23.19%
2023-12-31$200.52M56.29%
2022-12-31$128.30M-1.69%
2021-12-31$130.51M65.43%
2020-12-31$78.89M-13.20%
2019-12-31$90.89M15.60%
2018-12-31$78.63M-15.88%
2017-12-31$93.47M3.04%
2016-12-31$90.71M-2.23%
2015-12-31$92.78M53.12%
2014-12-31$60.59M115.02%
2013-12-31$28.18M8.46%
2012-12-31$25.98M-23.27%
2011-12-31$33.86M1922.88%
2010-12-31$1.67M1140.00%
2009-12-31$135.00K-85.02%
2008-12-31$901.00K-58.34%
2007-12-31$2.16M-

Pacific Biosciences of California generated $154.01M in revenue during NA 2024, up -23.19% compared to the previous quarter, and up 169.45% compared to the same period a year ago.

Pacific Biosciences of California Revenue by Quarter

DateRevenueChange
2025-03-31$37.15M-5.28%
2024-12-31$39.22M-1.86%
2024-09-30$39.97M10.98%
2024-06-30$36.01M-7.21%
2024-03-31$38.81M-33.50%
2023-12-31$58.36M4.79%
2023-09-30$55.69M17.06%
2023-06-30$47.57M22.30%
2023-03-31$38.90M42.21%
2022-12-31$27.35M-15.34%
2022-09-30$32.31M-8.90%
2022-06-30$35.47M6.92%
2022-03-31$33.17M-7.90%
2021-12-31$36.02M3.24%
2021-09-30$34.89M13.97%
2021-06-30$30.61M5.56%
2021-03-31$29.00M6.86%
2020-12-31$27.14M42.21%
2020-09-30$19.08M11.74%
2020-06-30$17.08M9.48%
2020-03-31$15.60M-44.15%
2019-12-31$27.93M27.45%
2019-09-30$21.91M-10.99%
2019-06-30$24.62M49.90%
2019-03-31$16.43M-15.88%
2018-12-31$19.53M7.52%
2018-09-30$18.16M-15.84%
2018-06-30$21.58M11.45%
2018-03-31$19.36M-22.35%
2017-12-31$24.93M5.90%
2017-09-30$23.55M17.30%
2017-06-30$20.07M-19.43%
2017-03-31$24.91M-3.14%
2016-12-31$25.72M2.40%
2016-09-30$25.12M21.07%
2016-06-30$20.75M8.47%
2016-03-31$19.13M-47.28%
2015-12-31$36.28M160.70%
2015-09-30$13.92M-44.20%
2015-06-30$24.94M41.34%
2015-03-31$17.64M4.38%
2014-12-31$16.90M-18.03%
2014-09-30$20.62M80.51%
2014-06-30$11.43M-1.86%
2014-03-31$11.64M27.47%
2013-12-31$9.13M23.07%
2013-09-30$7.42M22.70%
2013-06-30$6.05M8.43%
2013-03-31$5.58M-5.10%
2012-12-31$5.88M111.74%
2012-09-30$2.78M-61.93%
2012-06-30$7.29M-27.37%
2012-03-31$10.04M-19.33%
2011-12-31$12.44M18.30%
2011-09-30$10.52M-1.04%
2011-06-30$10.63M3837.04%
2011-03-31$270.00K-3.57%
2010-12-31$280.00K27.27%
2010-09-30$220.00K-65.02%
2010-06-30$629.00K15.41%
2010-03-31$545.00K303.70%
2009-12-31$135.00K100.00%
2009-09-30--

Pacific Biosciences of California generated $37.15M in revenue during Q1 2025, up -5.28% compared to the previous quarter, and up 63.67% compared to the same period a year ago.

Pacific Biosciences of California Revenue Breakdown


Pacific Biosciences of California Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 22Dec 21Dec 20Dec 19
Consumable$70.37M$59.98M$52.18M$31.14M$32.62M
Product$136.15M$108.70M$113.50M$65.42M$77.74M
Service And Other$17.86M$19.61M$17.01M$13.47M$13.15M
Instrument$65.78M$48.72M$61.32M$34.28M$45.13M

Pacific Biosciences of California's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product (46.92%), Consumable (24.25%), Instrument (22.67%), and Service And Other (6.16%).

Quarterly Revenue by Product

Product/ServiceMar 25Dec 24Sep 24Mar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Product$31.11M$65.84M$35.30M$35.01M$51.56M$43.66M$34.65M$22.77M$27.51M$30.18M$28.24M$30.50M$26.53M$25.30M$23.63M$15.75M$13.76M$12.29M$24.55M$18.48M
Instrument$11.02M$29.96M$16.79M$19.02M$34.69M$29.92M$20.70M$11.44M$15.62M$15.55M$45.15M$14.28M$14.94M$7.73M$8.93M$4.02M$11.58M---
Consumable$20.10M$35.88M$18.51M$15.98M$16.87M$13.73M$13.95M$16.07M$14.56M$12.69M$37.19M$12.25M$10.36M$8.02M$4.82M$8.27M$6.90M---
Service And Other$6.04M$9.39M$4.67M$3.80M$4.13M$3.92M$4.25M$4.58M$4.80M$5.29M$4.93M$4.38M$4.08M$3.69M$3.51M$3.33M$3.32M$3.31M$3.38M$3.43M

Pacific Biosciences of California's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Product (45.58%), Consumable (29.44%), Instrument (16.14%), and Service And Other (8.85%).

Pacific Biosciences of California Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 22Dec 21Dec 20Dec 19
EMEA$34.59M----
Americas$78.71M----
Asia Pacific$40.71M$36.15M$35.72M$22.55M$26.61M
UNITED STATES$75.30M----
Europe-$22.60M$30.27M$19.07M$19.60M
North America-$69.56M$64.52M$37.28M$44.68M

Pacific Biosciences of California's latest annual revenue breakdown by geography, as of Dec 24: Americas (34.32%), UNITED STATES (32.84%), Asia Pacific (17.75%), and EMEA (15.09%).

Quarterly Revenue by Country

CountryMar 25Dec 24Sep 24Mar 24Sep 23Jun 23Mar 23Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Sep 20Jun 20Mar 20Sep 19Jun 19Mar 19Sep 18
EMEA$9.24M$17.12M$9.12M$8.36M$10.99M$10.73M$7.87M-------------
Asia Pacific$11.61M$17.19M$10.74M$12.78M$15.72M$12.88M$11.96M$9.57M$8.01M$8.39M$9.17M$9.77M$8.52M$5.77M$4.43M$4.44M$6.58M$6.99M$4.37M$6.29M
Americas$16.30M$40.93M$20.11M$17.68M$28.98M$23.96M$19.07M-------------
Europe-------$6.00M$5.74M$5.70M$6.35M$6.49M$8.32M$4.34M$4.19M$3.40M$4.94M$3.41M$3.06M$2.91M
North America-------$16.74M$21.72M$19.08M$19.37M$14.35M$12.16M$8.97M$8.46M$7.76M$10.39M$14.22M$8.99M$8.96M

Pacific Biosciences of California's latest quarterly revenue breakdown by geography, as of Mar 25: Americas (43.88%), Asia Pacific (31.25%), and EMEA (24.87%).

Pacific Biosciences of California Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TWSTTwist Bioscience$312.97M$92.79M
PACBPacific Biosciences of California$154.01M$37.15M
CRSPCRISPR Therapeutics$37.31M$35.00M
NTLAIntellia Therapeutics-$12.87M
EDITEditas Medicine--

PACB Revenue FAQ


What is Pacific Biosciences of California’s yearly revenue?

Pacific Biosciences of California's yearly revenue for 2024 was $154.01M, representing a decrease of -23.19% compared to 2023. The company's yearly revenue for 2023 was $200.52M, representing an increase of 56.29% compared to 2022. PACB's yearly revenue for 2022 was $128.3M, representing a decrease of -1.69% compared to 2021.

What is Pacific Biosciences of California’s quarterly revenue?

Pacific Biosciences of California's quarterly revenue for Q1 2025 was $37.15M, a -5.28% decrease from the previous quarter (Q4 2024), and a -4.27% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $39.22M, a -1.86% decrease from the previous quarter (Q3 2024), and a -32.79% decrease year-over-year (Q4 2023). PACB's quarterly revenue for Q3 2024 was $39.97M, a 10.98% increase from the previous quarter (Q2 2024), and a -28.23% decrease year-over-year (Q3 2023).

What is Pacific Biosciences of California’s revenue growth rate?

Pacific Biosciences of California's revenue growth rate for the last 3 years (2022-2024) was 20.04%, and for the last 5 years (2020-2024) was 95.22%.

What are Pacific Biosciences of California’s revenue streams?

Pacific Biosciences of California's revenue streams in c 24 are Consumable, Product, Service And Other, and Instrument. Consumable generated $70.37M in revenue, accounting 24.25% of the company's total revenue, up 17.33% year-over-year. Product generated $136.15M in revenue, accounting 46.92% of the company's total revenue, up 25.25% year-over-year. Service And Other generated $17.86M in revenue, accounting 6.16% of the company's total revenue, down -8.88% year-over-year. Instrument generated $65.78M in revenue, accounting 22.67% of the company's total revenue, up 35.01% year-over-year.

What is Pacific Biosciences of California’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Pacific Biosciences of California was Product. This segment made a revenue of $136.15M, representing 46.92% of the company's total revenue.